Q&A List
What types of projects does TCA support?
TCA is built for innovators who need end-to-end CMC support for complex or technically challenging projects, including biologics, ADCs, high-potency and cytotoxic APIs, nano-formulations, advanced oral delivery systems, and sterile injectables, from preclinical through commercial scale.
What is TCA's role in my project?
TCA acts as a single business development interface. Its BD team listens to your needs, screens across the 17 members, and connects you with the most suitable partners, so you don't have to search and qualify dozens of CDMOs on your own.
Why is Taiwan a strategic base for CDMO partnerships?
TCA members form a tightly clustered CDMO ecosystem in Taiwan, located at the heart of Asia and within a few hours of major cities like Tokyo, Seoul, Shanghai, and Hong Kong. This geographic concentration enables seamless supply-chain integration, efficient logistics, and scalable capacity across multiple sites.
Who is behind TCA?
TCA operates as an industry alliance under Taiwan BIO (TBIO). TBIO supports the members' joint business development and global marketing efforts by helping them present a unified face to international partners.
What can I expect from a TCA partnership?
TCA emphasizes quality, integrity, respect for IP, transparency, customer loyalty, and urgency in solving problems. The alliance is designed to be both technically sophisticated and highly customer-centric.
What problem does TCA solve for biotech and pharma companies?
Finding a reliable CDMO partner and building a resilient supply chain takes time and carries risk. TCA provides a single, trusted entry point into a mature CDMO ecosystem, enabling you to quickly identify suitable partners, access advanced technologies, and reduce risks related to capacity, quality, and supply-chain continuity.
What experience and track record do TCA members have?
Collectively, TCA members bring decades of CDMO experience with $7.8B+ USD combined market cap, 300+ drug substance DMFs, 800+ CDMO projects delivered, and more than 80 commercialized products. The alliance has completed 117 GMP inspections with an excellent compliance record. Member products are supplied to all major regions worldwide.
What is the Taiwan CDMO Alliance (TCA)?
TCA is an alliance of 17 well-established CDMOs in Taiwan that work together to support drug developers from early R&D through to commercial manufacturing. The members cover both drug substance and drug product across small molecules, biologics, peptides, ADCs, and more.